Nav: Home

Screening to blame for thyroid cancer 'epidemic' in South Korea

November 30, 2016

The current "epidemic" of thyroid cancer in South Korea is due to an increase in the detection of small tumours, most likely as a result of overdetection by screening, finds a study published by The BMJ today.

The researchers say concerted efforts are needed at a national level to reduce unnecessary thyroid ultrasound examinations in the general population.

South Korea has the highest incidence rate of thyroid cancer in the world. Between 1999 to 2009, rates of thyroid cancer increased by more than sevenfold, from 6.3 per 100,000 to 47.5 per 100,000 people. The economic burden of thyroid cancer in South Korea also increased around sevenfold, from $257m in 2000 to $1724m in 2010.

Overdiagnosis is believed to be the most plausible explanation.

Overdiagnosis refers to the detection of harmless cancers that will not cause symptoms or death during a patient's lifetime. But because it is not possible to distinguish between lethal and harmless cancers, all cancers detected mainly by screening are treated.

This exposes people to the potential side effects of treatment, but without an equal expectation of benefit, because the cancer is unlikely to advance.

However, some sceptics remain unconvinced. So to investigate whether screening for thyroid cancer led to the current "epidemic" in South Korea, a team led by Jin Soo Lee at the National Cancer Center Research Institute in Goyang, analysed the medical records of 5,796 thyroid cancer patients diagnosed in 1999, 2005, and 2008.

Most participants were women with an average age of 47 years. Age-standardised incidence of thyroid cancer was estimated, and the changes in incidence between 1999 and 2008 were examined according to how the tumour was detected (by screening, by clinical symptoms associated with thyroid disease, or unspecified).

Between 1999 and 2008, they found more than a sixfold increase in thyroid cancer incidence, from 6.4 to 40.7 per 100,000 people.

Of the increase, 94% (34 per 100,000 people) were for tumours less than 20 mm, which were detected mainly by screening and 97% of the total increase was for localised and regional stage tumours.

Even where cases were clinically detected, 99.9% of the increase (6.4 per 100,000 people) over the same period were for tumours less than 20 mm.

"Our study shows that the increase in the incidence of thyroid cancer in South Korea mainly resulted from overdetection, most likely as a result of widespread use of sensitive imaging tools (eg. ultrasound examination)," say the authors.

"Considering the increase in thyroid cancer incidence, the financial burden of using ultrasound to detect small tumours (and the often unnecessary subsequent surgery) is expected to rise rapidly," they warn.

They call for concerted efforts at national level "to reduce unnecessary ultrasound examination of the thyroid in the asymptomatic general population, unless clinically indicated."

In a linked editorial, US researchers say these findings "strongly suggest that the increase is due to overdiagnosis rather than an as yet unidentified new risk factor. Even more importantly, their data suggest that we might need to re-examine what we include in our definition of subclinical or indolent disease," they add.
-end-
Research: Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study http://www.bmj.com/content/355/bmj.i5745

Editorial: Overdiagnosis of thyroid cancer http://www.bmj.com/content/355/bmj.i6312

About BMJ

BMJ is a healthcare knowledge provider that aims to advance healthcare worldwide by sharing knowledge and expertise to improve experiences, outcomes and value. For a full list of BMJ products and services, please visit bmj.com

BMJ

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...